Sask. lab says its COVID-19 vaccine candidate has been found safe, issues open call for volunteers to receive it
The COVID-19 vaccine developed by the Vaccine and Infectious Disease Organization (VIDO) at the University of Saskatchewan is safe, the lab announced Wednesday.
The most common reactions from the Phase 1 clinical trial for the vaccine, named COVAC-2, were a headache and mild injection site pain, which VIDO says are common after most immunizations.
In addition, even the lowest vaccine dose significantly increased the participants’ antibody levels, including neutralizing antibodies against SARS-CoV-2, VIDO says.
“The data continues to demonstrate the safety of our subunit vaccine COVAC-2,” Dr. Volker Gerdts, director and CEO of VIDO, said in a news release.
“We are encouraged by the vaccine’s ability to generate a significant immune response, even at the lowest dose tested.”
Subunit vaccines such as COVAC-2 contain purified viral proteins that are not infectious and the technology offers a history of safety and ease of storage and transport, VIDO says.
Participants continue to be recruited for the clinical trial in Halifax and a new clinical trial site will also open in Saskatoon later this summer.
Those 18 years and older who have not been infected with COVID-19 or received an authorized COVID-19 vaccine are eligible to volunteer.
They can contact the Clinical Trial Support Unit at ctsu@usask.ca or 306-978-8300.
CTVNews.ca Top Stories
There's actually no such thing as vegetables. Here's why you should eat them anyway
The rumours are true: Vegetables aren't real — that is, in botany, anyway. While the term fruit is recognized botanically as anything that contains a seed or seeds, vegetable is actually a broad umbrella term.
'It looked so legit': Ontario man pays $7,700 for luxury villa found on Booking.com, but the listing was fake
An Ontario man says he paid more than $7,700 for a luxury villa he found on a popular travel website -- but the listing was fake.
The Met Gala was in full bloom with Zendaya, Jennifer Lopez, Mindy Kaling among the standout stars
The Met Gala and its fashionista A-listers on Monday included Jennifer Lopez, Zendaya and a parade of others in a swirl of flora and fauna looks on a green-tinged carpet lined by live foliage.
Israeli forces seize Rafah border crossing in Gaza, putting ceasefire talks on knife's edge
Israeli tanks seized control of Gaza's vital Rafah border crossing on Tuesday as Israel brushed off urgent warnings from close allies and moved into the southern city even as cease-fire negotiations with Hamas remained on a knife's edge.
Canadian cadets rock mullets and place second at U.S. military competition
Sporting mullets, Canadian Armed Forces officer cadets placed second in an annual military skills competition in the U.S.
Highlights from the 2024 Met Gala exhibit: Sleeping Beauty would wake up for these gowns
Sure, she was a royal princess and all. But there’s no way Sleeping Beauty — either before or after her nap — ever had quite the fabulous wardrobe that’s been assembled at the Metropolitan Museum of Art.
Noelia Voigt resigns as Miss USA, citing her mental health
Noelia Voigt, who was crowned Miss USA in November 2023, has announced she is resigning from her role, saying the decision is in the best interest of her mental health.
Putin begins his fifth term as president, more in control of Russia than ever
Vladimir Putin began his fifth term Tuesday as Russian leader at a glittering Kremlin inauguration, setting out on another six years in office after destroying his political opponents, launching a devastating war in Ukraine and concentrating all power in his hands.
Winnipeg man admits to killing four women, argues he's not criminally responsible
Defence lawyers of Jeremy Skibicki have admitted in court the accused killed four Indigenous women, but argues he is not criminally responsible for the deaths by way of mental disorder – this latest development has triggered a judge-alone trial rather than a jury trial.